Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Angiology
Cypher Sirolimus-eluting coronary stent data featured at meeting
June 17th, 2005
Clinical data regarding the use of the Cypher Sirolimus-eluting Coronary Stent in complex patient populations were presented at the 2005 EuroPCR Congress, May 24-27 in Paris, France. The Cypher Stent is the most studied drug-eluting stent available and has been used by doctors to treat more than one million patients worldwide. Several clinical presentations examined the safety profile, efficacy and clinical performance of the Cypher Stent in patients with complex coronary artery disease such as diabetics, which present some of the most challenging cases for cardiologists today. The presentations included a diabetic sub-group...
Source: Drug Week (2005-06-17)
|
